
Keywords: ADME; absorption, distribution, metabolism and excretion; AUC; area under the blood/plasma concentration time curve; BMDL; lower 95% confidence limit of the benchmark dose; Cmax; maximum blood/plasma concentration; NOAEL; no-observed-adverse-effect-level;